These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10794094)

  • 1. Polymerase chain reaction in detecting hepatitis C virus among blood donors.
    Mosley JW; Nowicki MJ; Wang LF; Laskus T; Rakela JL
    Dev Biol (Basel); 2000; 102():93-6. PubMed ID: 10794094
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic tests: Hepatitis C virus-related antibody].
    Tanaka T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():411-4. PubMed ID: 16111288
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
    Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
    J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis.
    Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M
    Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus RNA viremia in Central Africa.
    Cancré N; Grésenguet G; Mbopi-Kéou FX; Kozemaka A; Si Mohamed A; Matta M; Fournel JJ; Bélec L
    Emerg Infect Dis; 1999; 5(3):484-5. PubMed ID: 10341195
    [No Abstract]   [Full Text] [Related]  

  • 6. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.
    Attia MA; Zekri AR; Goudsmit J; Boom R; Khaled HM; Mansour MT; de Wolf F; el-Din HM; Sol CJ
    J Clin Microbiol; 1996 Nov; 34(11):2665-9. PubMed ID: 8897161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
    Alvarez M; Planelles D; Vila E; Montoro J; Franco E
    Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of the source of infection through HCV genotyping: HCV look-back II.
    da Silva Cardoso M; Koerner K; Epple S; Dengler T; Kerowgan M; Kubanek B
    Vox Sang; 1995; 69(2):155-7. PubMed ID: 8585205
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serological and molecular genetic markers of hepatitis C virus in infected donors].
    Zubkova NV; Filatova EV; Zubov SV
    Vopr Virusol; 2010; 55(5):34-6. PubMed ID: 21260994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.
    Andrea P; Kupek E; Genovez G; Martins JT; Barban GB
    Transfus Med; 2015 Apr; 25(2):125-7. PubMed ID: 25720742
    [No Abstract]   [Full Text] [Related]  

  • 11. An easy dipstick assay for anti-core antibodies to screen blood donors for hepatitis C virus viremia.
    Mulyanto ; Suwignyo S; Tsauri S; Itoh K; Mizui M; Tsuda F; Okamoto H; Yoshizawa H; Mishiro S
    Vox Sang; 1996; 70(4):229-31. PubMed ID: 9123929
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina.
    del Pino N; Oubiña JR; Rodríguez-Frías F; Esteban JI; Buti M; Otero T; Gregori J; García-Cehic D; Camos S; Cubero M; Casillas R; Guàrdia J; Esteban R; Quer J
    World J Gastroenterol; 2013 Sep; 19(35):5813-27. PubMed ID: 24124326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.
    Busch MP; Tobler L; Quan S; Wilber JC; Johnson P; Polito A; Steane E; Zola A; Bahl C; Nelles M
    Transfusion; 1993 Jan; 33(1):84-8. PubMed ID: 7678710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.
    Tsai SL; Chen PJ; Hwang LH; Kao JH; Huang JH; Chang TH; Chen DS
    J Hepatol; 1994 Sep; 21(3):403-11. PubMed ID: 7530738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of hepatitis C virus genotypes among blood donors from mid-west region of Brazil.
    Martins RM; Teles SA; Freitas NR; Motta-Castro AR; Souto FJ; Mussi A; Amorim RM; Martins CR
    Rev Inst Med Trop Sao Paulo; 2006; 48(1):53-5. PubMed ID: 16547582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
    Lin H; Chen X; Zhu S; Mao P; Zhu S; Liu Y; Huang C; Sun J; Zhu J
    Intervirology; 2016; 59(4):204-210. PubMed ID: 28208127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interpretation of hepatitis C virus serology: immunoblot and genome amplification].
    Maniez-Montreuil M; Dubois F
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():25s-30s. PubMed ID: 10919220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
    León P; Echevarría JM
    Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
    Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.